Trial intelligence / Profile preview

BLI4900 (Sutab) for bowel preparation in adults

NCT03328507Phase 2Completed

Sponsor
Braintree Laboratories
Start
Nov 2017
Primary completion
Nov 2019
Modality
Polymer-based Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Suflave, sponsored by Braintree Laboratories. Started Nov 2017; status: completed.

02

Drugs

Suflave

Beyond the preview

Go deeper on NCT03328507.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03328507.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call